Expression of miR-29a among pediatric B-ALL cases varies significantly (high levels in BCR-ABL1 cases and low levels in TCF3-r and KMT2A-r cases) [29,62,69,79,100]. This evidence concerns the gene KMT2A and precursor B-cell acute lymphoblastic leukemia.